Human REG I gene is up-regulated in intrahepatic cholangiocarcinoma and its precursor lesions

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
K HaradaY Nakanuma

Abstract

The Reg I gene (regenerating gene) and its product (Reg protein) are a regenerating and/or proliferating factor(s) of pancreatic islet cells. The ectopic expression of REG Ialpha was shown in colorectal carcinomas, suggesting that REG Ialpha is related to their carcinogenesis. In this study, we examined the expression of REG I in intrahepatic cholangiocarcinoma (ICC) and its precursor lesion (biliary dysplasia). By polymerase chain reaction and in situ hybridization (ISH) studies using a total of 16 fresh liver specimens, REG Ialpha mRNA was demonstrated in 6 of 11 (55%) ICC cases, but in 0 of 5 (0%) normal livers. Immunohistochemistry for REG I protein was performed in 100 formalin-fixed, paraffin-embedded sections obtained from the 18 cases of ICC alone, 45 hepatolithiasis with ICC (n = 19) or biliary dysplasia (n = 26), 21 hepatolithiasis alone (all with hyperplasia), and 16 normal livers. In ICC, the expression of REG I protein was significantly dependent on the histologic differentiation; 12 of 13 (92%) cases in papillary and well-differentiated, 6 of 16 (38%) cases in moderately differentiated, and 0 of 8 (0%) cases in poorly differentiated types. Moreover, in the lesions of hyperplasia, low-grade dysplasia, and high-grad...Continue Reading

Citations

Oct 11, 2003·Cancer Letters·Yuwei ZhangGuofeng Wang
Mar 31, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Hidetsugu YamagishiTakahiro Fujimori
Mar 1, 2002·Immunology and Cell Biology·Ian R Mackay
Feb 20, 2002·Journal of Gastroenterology and Hepatology·K Dohmen
Jun 6, 2003·Pathology International·Yasuni Nakanuma, Kenichi Harada
Feb 22, 2008·Journal of Gastroenterology and Hepatology·Daisuke ChinukiYoshikazu Kinoshita
Sep 11, 2008·Annals of Surgical Oncology·Yasuhiro SasakiJun-ichi Ogawa
Feb 9, 2008·Annals of Surgical Oncology·Kaori HayashiJun-ichi Ogawa
Jun 22, 2011·Journal of Cancer Research and Clinical Oncology·Jeong Youp ParkSi Young Song
Nov 22, 2015·Expert Opinion on Therapeutic Targets·Shin Takasawa
Mar 31, 2015·Oncology Reports·Ken HaraHiroto Miwa
Sep 3, 2013·The Journal of Surgical Research·Secil AkAbdullah Zorluoglu
Sep 1, 2009·Human Pathology·Hidehiko TamuraMasaru Miyazaki
Jan 27, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J GengQ Ding
Sep 25, 2007·Regulatory Peptides·V GigouxM Dufresne
Mar 2, 2005·Internal Medicine Journal·L L LeeJ Rowland
Mar 26, 2003·Liver International : Official Journal of the International Association for the Study of the Liver·Kenichi HaradaYasuni Nakanuma
Nov 27, 2008·Cancer Science·Kaori HayashiToshihiro Sugiyama
Aug 19, 2006·Journal of Surgical Oncology·King-Teh LeeShih-Wen Hu
Jan 26, 2010·International Journal of Cancer. Journal International Du Cancer·Lin ZhouYaozong Yuan
Oct 30, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yoshihiro MinamiyaJun-Ichi Ogawa
Mar 17, 2009·Biochemical and Biophysical Research Communications·Jingshu WangToshihiro Sugiyama
Nov 9, 2002·Journal of Gastroenterology and Hepatology·Takahito SaitoYasuni Nakanuma
Jun 6, 2019·American Journal of Physiology. Cell Physiology·Shawna DowningEmmanuel S Tzanakakis
Dec 12, 2003·World Journal of Gastroenterology : WJG·Yu-Wei ZhangMao-De Lai
Nov 2, 2017·Biochemistry and Biophysics Reports·Chikatsugu TsuchidaShin Takasawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.